Acorda Therapeutics
ACOR
#10358
Rank
NZ$1.37 M
Marketcap
$1.11
Share price
0.00%
Change (1 day)
-95.67%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -NZ$0.44 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are NZ$0.11 Billion. In 2023 the company made an earning of -NZ$0.45 Billion a decrease over its 2022 earnings that were of -NZ$8.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.44 Billion-2.19%
2023 -NZ$0.45 Billion4848.63%
2022 -NZ$8.93 Million-93.25%
2021 -NZ$0.14 Billion2.52%
2020 -NZ$0.13 Billion-69.45%
2019 -NZ$0.43 Billion-700.62%
2018 NZ$70.25 M-118.02%
2017 -NZ$0.39 Billion805.99%
2016 -NZ$43.05 Million-173.88%
2015 NZ$58.25 M-6.58%
2014 NZ$62.36 M20.19%
2013 NZ$51.88 M18.7%
2012 NZ$43.71 M-26.54%
2011 NZ$59.5 M
2009 -NZ$0.14 Billion10.65%
2008 -NZ$0.13 Billion86.17%
2007 -NZ$65.96 Million68.1%
2006 -NZ$39.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$10.55 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.90 B-299.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.13 Billion-71.85%๐Ÿ‡ฉ๐Ÿ‡ช Germany
NZ$0.43 B-195.95%๐Ÿ‡บ๐Ÿ‡ธ USA